Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,904.00 0.50 (0.03%)

Bid:

1,903.50

Ask:

1,904.00

Spread: 0.50 (0.026%)

Market Cap: £76.33b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

TOP NEWS: GSK inks licensing deal with CureVac for flu and Covid drugs

(Alliance News) - GSK PLC on Wednesday restructured an existing collaboration with CureVac NV into a new licensing agreement to take control of develo...

GSK buys COVID, influenza vaccines from retrenching CureVac

July 3 (Reuters) - British drugmaker GSK on Wednesday bought partner CureVac out of their alliance on influenza and COVID-19 vaccine development, bo...

LONDON BRIEFING: Keywords Studios agrees takeover by EQT

(Alliance News) - Stocks in London are expected to open higher on Wednesday, as investors shake off pre-election nerves.

London close: Stocks fall on EU inflation, US jobs data

(Sharecast News) - London stocks closed lower on Tuesday as investors digested eurozone inflation data and a modest increase in US job openings.

London's FTSE 100 hits over two-month low amid election jitters

FTSE 100 down 0.6%, FTSE 250 off 0.1% *

Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by judge

July 1 (Reuters) - A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming th...

IN BRIEF: GSK reaches settlement over Zantac case in Illinois

GSK PLC - London based pharmaceuticals company - Reaches confidential settlement with Martin Gross resolving the case he filed in Illinois state court...

European shares subdued ahead of economic data, French elections; H&M plunges

H&M tumbles after missing quarterly profit forecasts *